Infectious Disease Diagnostics System
Molecular diagnosis and screening of infectious diseases (e.g., STIs)
Key Facts
About Kryptos Biotechnologies
Kryptos Biotechnologies is a private, venture-backed diagnostics company leveraging its proprietary photothermal heating technology to create ultrafast, accurate PCR systems for decentralized clinical settings. Its lead application is an integrated sample-to-answer molecular diagnostic platform for infectious diseases, delivering results in approximately 25 minutes. The company has secured significant non-dilutive funding through grants like the NIH RADx and the RIGHT Foundation, alongside a $10 million Series A round led by Osang Healthcare, and has established a strategic partnership and license agreement with LG Chem. Kryptos operates in the high-growth point-of-care diagnostics market, aiming to translate technological speed and simplicity into improved clinical decision-making.
View full company profile